HealthcareServices

Global Hepatitis C Market Set for Strong Expansion, Reaching $153.66 Billion With 15.4% CAGR by 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Hepatitis C Market covering 2026–2035?

The hepatitis c market has seen rapid expansion in recent years. Its size is expected to increase from $75.72 billion in 2025 to $86.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be attributed to factors such as improved blood screening methods, the broader availability of antiviral drugs, a rise in diagnosis rates, increased awareness of viral hepatitis, and backing from public health initiatives.

The market size for hepatitis c is projected to undergo swift growth over the next few years. By 2030, this market is anticipated to reach $153.67 billion, expanding at a compound annual growth rate (CAGR) of 15.4%. This projected growth during the forecast period is fueled by several factors, including health organizations setting more ambitious elimination targets, increased investment in hepatitis screening, the wider adoption of streamlined treatment protocols, the broader reach of telemedicine-based care, and improved access in developing markets. Key developments expected in this period encompass the greater uptake of direct-acting antivirals, an elevated emphasis on early screening initiatives, wider availability of curative treatment options, the spread of public health awareness campaigns, and a stronger focus on ensuring treatment compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Hepatitis C Market?

Rising viral infections are projected to drive the expansion of the hepatitis C market. Viral infections are defined as illnesses caused by a virus in the body. Treatments for hepatitis C work by eradicating the viral infection and restoring the immune response in patients following viral clearance, thereby reducing the viral load. For instance, in August 2024, the Centers for Disease Control and Prevention, a US-based public health agency, indicated that the percentage of individuals with Parvovirus B19, a seasonal respiratory viral infection, rose across all age groups, increasing from 3% during 2022–2024 to 10% in June 2024. Among these, children aged 5–9 years showed the most significant surge, with prevalence jumping from 15% during 2022–2024 to 40% by June 2024. Additionally, the proportion of pooled samples containing parvovirus B19 DNA levels grew substantially from 1.5% in December 2023 to 19.9% in June 2024. Thus, the growth in viral infections is a key driver for the hepatitis C market.

What Leading Segments Are Studied In The Hepatitis C Market?

The hepatitis c market covered in this report is segmented –

1) By Type: Chronic Hepatitis C, Acute Hepatitis C

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6

2) By Acute Hepatitis C: Symptomatic, Asymptomatic

Which Trends Are Guiding The Evolution Of The Hepatitis C Market?

Leading companies in the hepatitis C market are concentrating on developing sophisticated products, such as combined antigen and antibody diagnostic tests, to enhance the precision and effectiveness of early diagnosis and treatment. This type of dual diagnostic test identifies both the presence of hepatitis C virus (HCV) antigens and antibodies within a patient’s blood. For example, in July 2023, Roche Diagnostics, a Switzerland-based firm specializing in diagnostic tests, instruments, and digital solutions, introduced Elecsys HCV Duo in India. The Elecsys HCV Duo is a dual antigen and antibody diagnostic test engineered for the simultaneous detection of both the hepatitis C virus (HCV) antigen and antibodies from a single plasma or serum specimen. The test’s ability to detect both markers addresses the difficulty posed by asymptomatic early infections, which frequently remain undiagnosed because antibodies are often absent in the initial phases. By allowing for earlier detection of active infections, the Elecsys HCV Duo supports healthcare providers in initiating suitable treatment plans more swiftly, potentially curbing disease progression and transmission rates.

Which Leading Companies Dominate The Hepatitis C Market Share?

Major companies operating in the hepatitis c market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Hepatitis C Market?

North America was the largest region in the hepatitis C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hepatitis C Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Market 2026, By The Business Research Company

Hepatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Preventive Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795